Haiqin Yun

Alterations of biomarker profiles after neoadjuvant chemotherapy in breast cancer : tumor heterogeneity should be taken into consideration

Yan Wang, K. Mu, S. Lagercrantz, 2015 .

A standardized method for quantifying proliferation by Ki-67 and cyclin A immunohistochemistry in breast cancer.

A. Zetterberg, G. Auer, D. Ye, 2015, Annals of diagnostic pathology.

RETRACTED ARTICLE: SDF-1/CXCR4 Axis Regulates Cell Cycle Progression and Epithelial-Mesenchymal Transition via Up-regulation of Survivin in Glioblastoma

Jin-na Li, Yuliang Jiang, Ranran Shi, 2014, Molecular Neurobiology.

RETRACTED ARTICLE: SDF-1/CXCR4 Axis Regulates Cell Cycle Progression and Epithelial-Mesenchymal Transition via Up-regulation of Survivin in Glioblastoma

Jin-na Li, Yuliang Jiang, Ranran Shi, 2014, Molecular Neurobiology.

Retraction Note to “SDF-1/CXCR4 Axis Regulates Cell Cycle Progression and Epithelial-Mesenchymal Transition via Up-regulation of Survivin in Glioblastoma”

Jin-na Li, Yuliang Jiang, Ranran Shi, 2017, Molecular Neurobiology.

Over expression of hRad9 protein correlates with reduced chemosensitivity in breast cancer with administration of neoadjuvant chemotherapy

Qingrui Yang, K. Mu, Xiaofang Zhang, 2014, Scientific Reports.

Alterations of biomarker profiles after neoadjuvant chemotherapy in breast cancer: tumor heterogeneity should be taken into consideration

Yan Wang, Haiqin Yun, Xingchen Zhou, 2015, Oncotarget.